Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Gabriele Cerutti, Micah Rapp, Yicheng Guo, et al.
Structure (2021) Vol. 29, Iss. 7, pp. 655-663.e4
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Dynamics of SARS-CoV-2 Alpha (B.1.1.7) variant spread: The wastewater surveillance approach
Albert Carcereny, David García-Pedemonte, Adán Martínez-Velázquez, et al.
Environmental Research (2022) Vol. 208, pp. 112720-112720
Open Access | Times Cited: 24
Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis
Yingjie Zhang, Qing Li, Liang Luo, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108143-108143
Closed Access | Times Cited: 14
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu, Wei Xu, Zhenguo Chen, et al.
Protein & Cell (2021) Vol. 13, Iss. 9, pp. 655-675
Open Access | Times Cited: 32
Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
Narasimha M. Beeraka, Olga Sukocheva, Elena Lukina, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 21
Structural Immunology of SARS‐CoV‐2
Meng Yuan, Ian A. Wilson
Immunological Reviews (2024)
Open Access | Times Cited: 4
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference
Jennifer L. McKimm‐Breschkin, Alan Hay, Bin Cao, et al.
Antiviral Research (2021) Vol. 197, pp. 105227-105227
Open Access | Times Cited: 24
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants
Matthew Chang, Hanzhong Ke, Christian D. Coherd, et al.
EBioMedicine (2022) Vol. 80, pp. 104025-104025
Open Access | Times Cited: 17
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification
Rachel Harding, Yuanyun Xie, Nicholas S. Caron, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Acute Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy Is Associated with Placental Angiotensin-Converting Enzyme 2 Shedding
Elizabeth S. Taglauer, Elisha M. Wachman, Lillian J. Juttukonda, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 595-603
Open Access | Times Cited: 15
Antibody cocktail effective against variants of SARS-CoV-2
Kang-Hao Liang, Pao-Yin Chiang, Shih-Han Ko, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 20
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 697
Open Access | Times Cited: 8
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 8
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 40, pp. 8586-8602
Open Access | Times Cited: 8
SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion
David D. Ho, Qian Wang, Yicheng Guo, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 12
The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology, and Variants of Concern
Paul C. Guest, Prashant Kesharwani, Alexandra E. Butler, et al.
Advances in experimental medicine and biology (2023), pp. 3-26
Closed Access | Times Cited: 6
Why are some coronavirus variants more infectious?
Raju Mukherjee, Rohit Satardekar
PubMed (2021) Vol. 46
Closed Access | Times Cited: 13
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model
Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, et al.
Vaccine (2022) Vol. 40, Iss. 9, pp. 1289-1298
Open Access | Times Cited: 10
Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants
James Logue, Robert M. Johnson, Nita Patel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 11
Contributions of single-particle cryoelectron microscopy toward fighting COVID-19
Micah Rapp, Lawrence Shapiro, Joachim Frank
Trends in Biochemical Sciences (2021) Vol. 47, Iss. 2, pp. 117-123
Open Access | Times Cited: 11
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
Bernard Vanhove, Stéphane Marot, Ray T. Y. So, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11
Acute SARS-CoV-2 infection in pregnancy is associated with placental ACE-2 shedding
Elizabeth S. Taglauer, Elisha M. Wachman, Lillian J. Juttukonda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Pierce into Structural Changes of Interactions Between Mutated Spike Glycoproteins and ACE2 to Evaluate Its Potential Biological and Therapeutic Consequences
Zahra Sadat Hashemi, Mahboubeh Zarei, Shaden M. H. Mubarak, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Structural basis for antibody resistance to SARS-CoV-2 omicron variant
Gabriele Cerutti, Yicheng Guo, Lihong Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2
Meng Yuan, Yiquan Wang, Huibin Lv, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4

Scroll to top